Health Care · Biotechnology
Market capitalization divided by trailing twelve-month revenue. A valuation metric often used when earnings are negative or not meaningful.
Latest P/S Ratio
0.70x
As of Aug 31, 2026
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Aug 31, 2026 | 0.70x |
| Aug 26, 2026 | 0.70x |
| Jun 11, 2026 | 0.69x |
| May 29, 2026 | 0.69x |
| May 28, 2026 | 0.74x |
| May 27, 2026 | 0.74x |
| May 21, 2026 | 0.74x |
| May 18, 2026 | 0.74x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison